◆英語タイトル：Esperion Therapeutics Inc (ESPR) - Financial and Strategic SWOT Analysis Review
Esperion Therapeutics Inc (Esperion), a subsidiary of Pfizer Inc is a pharmaceutical company that develops and commercializes once-daily, oral and low-density lipoprotein cholesterol lowering therapies. The company develops oral therapies to treat patients with elevated low-density lipoprotein cholesterol (LDL-C). Its lead product candidate, Bempedoic acid is an ATP-citrate lyase inhibitor which is in Phase 3 clinical development that reduces elevated LDL-C levels in patients with hypercholesterolemia. The company also offers development of bempedoic acid in a fixed dose combination with ezetimibe, an LDL-C lowering therapy. Esperion is headquartered in Ann Arbor, Michigan, the US.
Esperion Therapeutics Inc Key Recent Developments
Feb 28,2019: Esperion provides Bempedoic Acid Franchise Development Program updates; Reports fourth quarter and full year 2018 financial results
Nov 01,2018: Esperion reports third quarter 2018 financial results
Aug 02,2018: Esperion provides Bempedoic Acid franchise development program updates; reports second quarter 2018 financial results
May 10,2018: Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Esperion Therapeutics
May 07,2018: Pomerantz Law Firm Announces the Filing of a Class Action against Esperion Therapeutics and Certain Officers – ESPR
This comprehensive SWOT profile of Esperion Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Esperion Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Esperion Therapeutics Inc – Key Information
Esperion Therapeutics Inc – Overview
Esperion Therapeutics Inc – Key Employees
Esperion Therapeutics Inc – Key Employee Biographies
Esperion Therapeutics Inc – Key Operational Heads
Esperion Therapeutics Inc – Major Products and Services
Esperion Therapeutics Inc – History
Esperion Therapeutics Inc – Company Statement
Esperion Therapeutics Inc – Locations And Subsidiaries
Esperion Therapeutics Inc – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
Esperion Therapeutics Inc – Business Description
Esperion Therapeutics Inc – Corporate Strategy
Esperion Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Esperion Therapeutics Inc – Strengths
Esperion Therapeutics Inc – Weaknesses
Esperion Therapeutics Inc – Opportunities
Esperion Therapeutics Inc – Threats
Esperion Therapeutics Inc – Key Competitors
Section 3 – Company Financial Performance Charts
Esperion Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Esperion Therapeutics Inc, Key Information
Esperion Therapeutics Inc, Key Ratios
Esperion Therapeutics Inc, Share Data
Esperion Therapeutics Inc, Major Products and Services
Esperion Therapeutics Inc, History
Esperion Therapeutics Inc, Key Employees
Esperion Therapeutics Inc, Key Employee Biographies
Esperion Therapeutics Inc, Key Operational Heads
Esperion Therapeutics Inc, Other Locations
Esperion Therapeutics Inc, Subsidiaries
Esperion Therapeutics Inc, Key Manufacturing facilities
Esperion Therapeutics Inc, Key Competitors
Esperion Therapeutics Inc, SWOT Analysis
Esperion Therapeutics Inc, Ratios based on current share price
Esperion Therapeutics Inc, Annual Ratios
Esperion Therapeutics Inc, Interim Ratios
Capital Market Ratios
List of Figures
Esperion Therapeutics Inc, Performance Chart
Esperion Therapeutics Inc, Ratio Charts
| ★海外企業調査レポート[Esperion Therapeutics Inc (ESPR)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら